# Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl

> **NCT05006118** · PHASE1 · COMPLETED · sponsor: **Altavant Sciences GmbH** · enrollment: 5 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Radio-labeled rodatristat ethyl 600 mg

## Key facts

- **NCT ID:** NCT05006118
- **Lead sponsor:** Altavant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-23
- **Primary completion:** 2021-10-06
- **Final completion:** 2021-10-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05006118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05006118, "Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05006118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*